Publications

Filter Year

Crystal structure of human peptidoglycan recognition protein I alpha bound to a muramyl pentapeptide from Gram-positive bacteria.
Guan R, Brown PH, Swaminathan CP, Roychowdhury A, Boons GJ, Mariuzza RA. 2006. Crystal structure of human peptidoglycan recognition protein I alpha bound to a muramyl pentapeptide from Gram-positive bacteria. Protein science : a publication of the Protein Society 15(5): 1199-206.
HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.
Bower JF, Li Y, Wyatt R, Ross TM. 2006. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies. Vaccine 24(26): 5442-51.
Multiple paths to multispecificity.
Mariuzza RA. 2006. Multiple paths to multispecificity. Immunity 24(4): 359-61.
Molecularly imprinted polymers for tobacco mosaic virus recognition.
Bolisay LD, Culver JN, Kofinas P. 2006. Molecularly imprinted polymers for tobacco mosaic virus recognition. Biomaterials 27(22): 4165-8.
Advanced drug delivery systems that target the vascular endothelium.
Ding BS, Dziubla T, Shuvaev VV, Muro S, Muzykantov VR. 2006. Advanced drug delivery systems that target the vascular endothelium. Molecular interventions 6(2): 98-112.
SNPs3D: candidate gene and SNP selection for association studies.
Yue P, Melamud E, Moult J. 2006. SNPs3D: candidate gene and SNP selection for association studies. BMC bioinformatics 7: 166.
Bioinspired vesicle restraint and mobilization using a biopolymer scaffold.
Zhu C, Lee JH, Raghavan SR, Payne GF. 2006. Bioinspired vesicle restraint and mobilization using a biopolymer scaffold. Langmuir : the ACS journal of surfaces and colloids 22(7): 2951-5.
Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases.
Njar VC, Gediya L, Purushottamachar P, Chopra P, Vasaitis TS, Khandelwal A, Mehta J, Huynh C, Belosay A, Patel J. 2006. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorganic & medicinal chemistry 14(13): 4323-40.
Coexistence of dihydrogen, blue- and red-shifting hydrogen bonds in an ultrasmall system: valine.
Yu W, Lin Z, Huang Z. 2006. Coexistence of dihydrogen, blue- and red-shifting hydrogen bonds in an ultrasmall system: valine. Chemphyschem : a European journal of chemical physics and physical chemistry 7(4): 828-30.
Rigorous performance evaluation in protein structure modelling and implications for computational biology.
Moult J. 2006. Rigorous performance evaluation in protein structure modelling and implications for computational biology. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 361(1467): 453-8.
An N-terminal sequence targets and tethers Na+ pump alpha2 subunits to specialized plasma membrane microdomains.
Song H, Lee MY, Kinsey SP, Weber DJ, Blaustein MP. 2006. An N-terminal sequence targets and tethers Na+ pump alpha2 subunits to specialized plasma membrane microdomains. The Journal of biological chemistry 281(18): 12929-40.
Using offset recombinant polymerase chain reaction to identify functional determinants in a common family of bacterial albumin binding domains.
Rozak DA, Alexander PA, He Y, Chen Y, Orban J, Bryan PN. 2006. Using offset recombinant polymerase chain reaction to identify functional determinants in a common family of bacterial albumin binding domains. Biochemistry 45(10): 3263-71.
Post-transcriptional regulation of thioredoxin by the stress inducible heterogenous ribonucleoprotein A18.
Yang R, Weber DJ, Carrier F. 2006. Post-transcriptional regulation of thioredoxin by the stress inducible heterogenous ribonucleoprotein A18. Nucleic acids research 34(4): 1224-36.
Crystallization of the class IV adenylyl cyclase from Yersinia pestis.
Smith N, Kim SK, Reddy PT, Gallagher DT. 2006. Crystallization of the class IV adenylyl cyclase from Yersinia pestis. Acta crystallographica. Section F, Structural biology and crystallization communications 62(Pt 3): 200-4.
Tyrosine-based "activatable pro-tag": enzyme-catalyzed protein capture and release.
Lewandowski AT, Small DA, Chen T, Payne GF, Bentley WE. 2006. Tyrosine-based "activatable pro-tag": enzyme-catalyzed protein capture and release. Biotechnology and bioengineering 93(6): 1207-15.